Publications

The publications of the ESLHO networks can be found on the following pages:

The publications from 2022 are also listed below:

EuroMRD  publications

  • Della Starza I, Eckert C,  Drandi D, Cazzaniga G. EuroMRD Consortium Minimal Residual Disease Analysis by Monitoring Immunoglobulin and T-Cell Receptor Gene Rearrangements by Quantitative PCR and Droplet Digital PCR. Methods Mol Biol. 2022;2453:79-89
  • Venn NC, Huang L, Hovorková L, Muskovic W, Wong M, Law T, Heatley SL, Khaw SL, Revesz T, Dalla Pozza L, Shaw PJ, Fraser C, Moore AS, Cross S, Bendak K, Norris MD, Henderson MJ, White DL, Cowley MJ, Trahair TN, Zuna J, Sutton R. Measurable residual disease analysis in paediatric acute lymphoblastic leukaemia patients with ABL-class fusions. Br J Cancer 2022 Sep;127:908-915
  • Svaton M, Skotnicova A, Reznicova A, Rennerova A, Valova T, Kotrova M, van der Velden VHJ, Brüggemann M, Darzentas N, Langerak AW, Zuna J, Stary J, Trka J, Fronkova E. NGS better discriminates true MRD positivity for the risk stratification of childhood ALL treated on MRD-based protocol. Blood 2022 Oct 14;doi: 10.1182/blood.2022017003
  • Kotrová M, Koopmann J, Trautmann H, Alakel N, Beck J, Nachtkamp K, Steffen B, Raffel S, Viardot A, Wethmar K, Darzentas N, Baldus CD, Gökbuget N, Brüggemann M. Blood Adv 2022;6:3006-3010
  • Zuna J, Hovorkova L, Krotka J, Koehrmann A, Bardini M, Winkowska L, Fronkova E, Alten J, Koehler R, Eckert C, Brizzolara L, Trkova M, Stuchly J, Zimmermann M, de Lorenzo P, Grazia Valsecchi M, Conter V, Stary J, Schrappe M, Biondi A, Trka J, Zaliova M, Cazzaniga G, Cario G. Minimal residual disease in BCR::ABL1-positive acute lymphoblastic leukemia: different significance in typical ALL and in CML-like disease. In: van Dongen JJM et al., eds. Abstract book of 11th ESLHO Symposium New developments in the ESLHO networks. Leiden: ESLHO; 2022. p.39-43.

EuroClonality publications:

  • Langerak AW. The Advent of Precision Immunology: Immunogenetics at the Center of Immune Cell Analysis in Health and Disease. Methods Mol Biol 2022;2453:1-5
  • Darzentas N. ARResT/Interrogate Immunoprofiling Platform: Concepts, Workflows, and Insights. Methods Mol Biol 2022;2453:571-584
  • Pott C, Kotrova M, Darzentas N, Brüggemann M, Khouja M, EuroClonality-NGS Working Group. cfDNA-Based NGS IG Analysis in Lymphoma. Methods Mol Biol 2022;2453:101-117
  • Langlois de Septenville A, Boudjoghra M, Bravetti C, Armand M, Salson M, Giraud M, Davi F. Immunoglobulin Gene Mutational Status Assessment by Next Generation Sequencing in Chronic Lymphocytic Leukemia. Methods Mol Biol 2022;2453:153-167
  • Stewart JP, Gazdova J, Srivastava S, Revolta J, Harewood L, Maurya M, Darzentas N, Gonzalez D. Immunoglobulin/T Cell Receptor Capture Strategy for Comprehensive Immunogenetics. Methods Mol Biol 2022;2453:133-152
  • van Bladel DAG, van der Last-Kempkes JLM, Scheijen B, Groenen PJTA, EuroClonality Consortium. Next-Generation Sequencing-Based Clonality Detection of Immunoglobulin Gene Rearrangements in B-Cell Lymphoma. Methods Mol Biol 2022;2453:7-42
  • Galigalidou C, Zaragoza-Infante L, Chatzidimitriou A, Stamatopoulos K, Psomopoulos F, Aganthangelidis A. Purpose-built immunoinformatics for BcR IG/TR repertoire data analysis. Methods Mol Biol 2022;2453:585-603
  • McCafferty N, Stewart JP, Darzentas N, Gazdova J, Catherwood M, Stamatopoulos K, Langerak AW, Gonzalez D; A novel next-generation sequencing capture-based strategy to report somatic hypermutation status using genomic regions downstream to immunoglobulin rearrangements. Haematologica 2022, Dec 29l doi: 10.3324/haematol.2022.281928
  • Stewart JP, McCafferty N, Darzentas N, Gazdova J, Catherwood M, Stamatopoulos K, Langerak AW, Gonzalez D. A novel next-generation sequencing capture-based strategy to report somatic hypermutation status using genomic regions downstream to immunoglobulin rearrangements. In: van Dongen JJM et al., eds. Abstract book of 11th ESLHO Symposium New developments in the ESLHO networks. Leiden: ESLHO; 2022. p.73-76
  • Bravetti C, Langlois de Septenville A, Armand M, Boudjoghra M, Salson M, Giraud M, Rosenquist R, Darzentas N, Ghia P, Langerak AW, Stamatopoulos K, Davi F, on behalf of ERIC and the EuroClonality-NGS working group. A reliable NGS-based methodology for determining IGHV gene mutational status in chronic lymphocytic leukemia. In: van Dongen JJM et al., eds. Abstract book of 11th ESLHO Symposium New developments in the ESLHO networks. Leiden: ESLHO; 2022. p.79-82
  • Khouja M, Genuardi E, Ferrero S, Alessandria B, Verhagen O, Homburg C, van der Velden VHJ, Gameiro P, García Sanz R, Medina Herrera A, Fronkova E, Brüggemann M, Dreyling M, Hoster E, Langerak AW, Darzentas N, Pal K, Stewart PJ, Gonzalez D, Pott C, on behalf of the EuroClonality-NGS Working Group. Comprehensive analysis of non-invasive genotyping and minimal residual disease (MRD) assessment in malignant lymphomas. In: van Dongen JJM et al., eds. Abstract book of 11th ESLHO Symposium New developments in the ESLHO networks. Leiden: ESLHO; 2022. p.85-90

EuroClonality/EuroMRD publications:

  • Villarese P, Abdo C, Bertrand M, Thonier F, Giraud M, Salson M, Macintyre E. One-Step Next-Generation Sequencing of Immunoglobulin and T-Cell Receptor Gene Recombinations for MRD Marker Identification in Acute Lymphoblastic Leukemia. Methods Mol Biol 2022;2453:43-59
  • van der Velden VHJ, Bastian L, Brüggemann M, Hartmann AM, Darzentas N. Immunoglobulin/T-Cell Receptor Gene Rearrangement Analysis Using RNA-Seq. Methods Mol Biol 2022;2453:61-77
  • Fronkova E, Svaton M, Trka J. Quality Control for IG /TR Marker Identification and MRD Analysis. Methods Mol Biol 2022;2453:91-99
  • Genuardi E, Alessandria B, Civita AM, Ferrero S. Targeted Locus Amplification as Marker Screening Approach to Detect Immunoglobulin (IG) Translocations in B-Cell Non-Hodgkin Lymphomas. Methods Mol Biol 2022;2453:119-132

EuroFlow publications

  • Sedek L, Flores-Montero J, van der Sluijs A, Kulis J, te Marvelde J, Philippé J, Böttcher S, Bitter WM, Caetano J, van der Velden VHJ, Sonneveld E, Buracchi C, Santos AH, Lima M, Szczepanski T, van Dongen JJM, Orfao A. Impact of Pre-Analytical and Analytical Variables Associated with Sample Preparation on Flow Cytometric Stainings Obtained with EuroFlow Panels. Cancers 2022 Jan 18;14
  • Muñoz-García N, Morán-Plata FJ, Villamor N, Lima M, Barrena S, Mateos S, Caldas C, van Dongen JJM, Orfao A, Almeida J. High-Sensitive TRBC1-Based Flow Cytometric Assessment of T-Cell Clonality in Tαβ-Large Granular Lymphocytic Leukemia. Cancers (Basel) 2022 Jan 14;14
  • Böttcher S, Engelmann R, Grigore G, Fernandez PC, Caetano J, Flores-Montero J, van der Velden VHJ, Novakova M, Philippé J, Ritgen M, Burgos L, Lecrevisse QA, Lange S, Kalina T, Verde J, Fluxa R, van Dongen JJM, Pedreira CE, Orfao A. Expert-independent classification of mature B-cell neoplasms using standardized flow cytometry: a multicentric study. Blood Adv 2022 Feb 8;6
  • Brouwer N, Matarraz S, Nierkens S, Hofmans M, Nováková M, da Costa ES, Fernandez P, Bras AE, de Mello FV, Mejstrikova E, Philippé J, Grigore GE, Pedreira CE, van Dongen JJM, Orfao A, van der Velden VHJ, On Behalf Of The EuroFlow Consortium. Immunophenotypic Analysis of Acute Megakaryoblastic Leukemia: A EuroFlow Study. Cancers (Basel) 2022 Mar 21;14
  • Verbeek MWC, Buracchi C, Laqua A, Nierkens S, Sedek L, Flores-Montero J, Hofmans M, Sobral de Costa E, Nováková M, Mejstrikova E, Barrena S, Kohlscheen S, Szczepanowski M, Kulis J, Oliveira E, Jugooa R, de Jong AX, Szczepanski T, Philippé J, van Dongen JJM, Orfao A, Brüggemann M, Gaipa G, van der Velden VHJ. Flow cytometric minimal residual disease assessment in B-cell precursor acute lymphoblastic leukaemia patients treated with CD19-targeted therapies - a EuroFlow study. Br J Haematol 2022 Apr;197
  • Bras AE, Matarraz S, Nierkens S, Fernández P, Philippé J, Aanei CM, de Mello FV, Burgos L, van der Sluijs-Gelling AJ, Grigore GE, van Dongen JJM, Orfao A, van der Velden VHJ, On Behalf Of The EuroFlow Consortium. Quality Assessment of a Large Multi-Center Flow Cytometric Dataset of Acute Myeloid Leukemia Patients-A EuroFlow Study. Cancers (Basel) 2022 Apr 15;14
  • Oliveira E, Costa ES, Ciudad J, Gaipa G, Sedek Ł, Barrena S, Szczepanski T, Buracchi C, Silvestri D, Siqueira PFR, Mello FV, Torres RC, Oliveira LMR, Fay-Neves IVC, Sonneveld E, van der Velden VHJ, Mejstrikova E, Ribera JM, Conter V, Schrappe M, van Dongen JJM, Land MGP, Orfao A, EuroFlow Consortium. Bone Marrow Stromal Cell Regeneration Profile in Treated B-Cell Precursor Acute Lymphoblastic Leukemia Patients: Association with MRD Status and Patient Outcome. Cancers (Basel) 2022 Jun 23;14
  • Neirinck J, Emmaneel A, Buysse M, Philippé J, Van Gassen S, Saeys Y, Bossuyt X, De Buyser S, van der Burg M, Pérez-Andrés M, Orfao A, van Dongen JJM, Lambrecht BN, Kerre T, Hofmans M, Haerynck F, Bonroy C. The Euroflow PID Orientation Tube in the diagnostic workup of primary immunodeficiency: Daily practice performance in a tertiary university hospital. Front Immunol 2022;13:937738
  • Munoz-Garcia N, Lima M, Villamor N, Morán-Plata FJ, Barrena S, Mateos S, Caldas C, Balanzategui A, Alcoceba M, Langerak AW, van Dongen JJM, Orfao A, Almeida J, on behalf of the EuroFlow Consortium. Utility of TRBC1-based flow cytometry assay as a simple, rapid and robust approach for routing assessment of T cell clonality. In: van Dongen JJM et al., eds. Abstract book of 11th ESLHO Symposium New developments in the ESLHO networks. Leiden: ESLHO; 2022. p.11-16
  • Van der Pan K, de Bruin-Versteeg S, Damasceno D, Hernández-Delgado A, van der Sluijs AJ, van den Bossche WBL, de Laat I, Díez P, Naber BAE, Diks AM, Berkowska MA, de Mooij B, Groenland RJ, de Bie F, Khatri I, Kassem S, de Jager AL, Louis A, Almeida J, van Gaans-van den Brink JAM, Barkoff AM, He Q, Ferwerda G, Versteegen P, Berbers G, Orfao O, van Dongen JJM, Teodosio C. Flow cytometric monitoring of innate myeloid immune cells in human blood. In: van Dongen JJM et al., eds. Abstract book of 11th ESLHO Symposium New developments in the ESLHO networks. Leiden: ESLHO; 2022. p.19-27

ESLHO publication:

  • Van Dongen JJM. Position, aims and new structure of the ESLHO consortia. In: van Dongen JJM et al., eds. Abstract book of 11th ESLHO Symposium New developments in the ESLHO networks. Leiden: ESLHO; 2022. p.57-69